Hanseatic Management Services Inc Seagen Inc. Transaction History

Hanseatic Management Services Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$137.51 - $190.8 $375,539 - $521,074	-2,731 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$164.63 - $211.93 $11,030 - $14,199	-67 Reduced 2.39%	2,731 $478,000
Q3 2020 Oct 29, 2020	BUY	$145.95 - $195.69 $408,368 - $547,540	2,798 New	2,798 $548,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.